GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Stanford's 2026 AI Index covers 400+ pages of data. Here's what search professionals should take from the adoption numbers, ...

AI factories are pushing data center power and cooling requirements beyond traditional limits, making integrated AI data ...

Titled Claude Design, the new model is designed to make polished visual work for experienced designers and newbies alike. The ...

A study on visual language models explores how shared semantic frameworks improve image–text understanding across ...

Anthropic today launched Claude Design, a new AI product for creating designs, prototypes, slides, and more. Claude Design ...

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...

Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...

AGIBOT, a global leading robotics company specializing in embodied intelligence, today announced a new generation of embodied ...

Manycore Tech debuts on Hong Kong's stock exchange today, following a $130 million IPO—and contributing to the Chinese city's ...

Anthropic has launched Claude Design, an AI tool that helps users create prototypes, presentations, and visual assets through ...

Anthropic launched Claude Design, an AI tool that turns text prompts into interactive prototypes, alongside its most powerful ...